Amarin Corp Plc (AMRN)

[Greymatter1]

AMRN will fold without an expansion of the usage being approved. They know it. They don't have the means to do battle with BP with only one drug in their pipeline and reluctant acceptance of the science in the medical community. Their clip has only 1 bullet in it. The target is over a mile away. They need a bulls-eye. Odds are low in getting it.
Moral of the story: your losses will become permanent without an overwhelming show from the Reduce It study many years from today. Of note: I admire the initiative many of the investors have taken to try to change things here. It was impressive and inspiring. But sometimes false hope is worse than no hope at all.

One more thing....don't call me Francis. My father called me Francis, once.